» Articles » PMID: 23597029

The Associations Between the Polymorphisms in the CTLA-4 Gene and the Risk of Graves' Disease in the Chinese Population

Overview
Journal BMC Med Genet
Publisher Biomed Central
Specialty Genetics
Date 2013 Apr 20
PMID 23597029
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The associations between the polymorphisms in Cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) gene and Graves' disease (GD) have been extensively investigated in Chinese population. However, the results were inconsistent. The objective of this study is to investigate the associations between the polymorphisms in CTLA-4 gene and the risk of GD by meta-analysis.

Methods: We searched Pubmed database, Medline (Ovid) database, CNKI database and Wanfang database, covering all studies until August 11, 2012. Statistical analysis was performed by using the Revman4.2 software and the Stata10.0 software.

Results: A total of 28 case-control studies concerning the most widely studied three polymorphisms [+49A/G(rs231775), -318C/T(rs5742909) and CT60(rs3087243)] for Chinese population in 21 publications were included. The results suggested that the G allele carriers (GG+GA) might have an increased risk of GD when compared with the AA homozygote carriers for the +49A/G polymorphism (GG+GA vs. AA: OR = 2.57, 95%CI = 1.87-3.52). However, as to the -318C/T polymorphism and CT60 polymorphism, the results indicated that the variant allele carriers might have decreased risks of GD when compared with the homozygote carriers (-318C/T: TT+TC vs. CC: OR = 0.78, 95%CI = 0.62-0.97; CT60: AA+AG vs. GG: OR = 0.64, 95%CI = 0.52-0.78).

Conclusions: The current meta-analysis indicated that the polymorphisms in the CLTA-4 gene might be risk factors for GD in the Chinese population. In future, more large-scale case-control studies are needed to validate these results.

Citing Articles

Increased cAMP-PKA signaling pathway activation is involved in up-regulation of CTLA-4 expression in CD4+ T cells in acute SIVmac239-infected Chinese rhesus macaques.

Tian R, Liu B, Zhao M, Cai Y, Zheng Y Virus Res. 2024; 341:199313.

PMID: 38244614 PMC: 10831101. DOI: 10.1016/j.virusres.2024.199313.


Gender Differences at the Onset of Autoimmune Thyroid Diseases in Children and Adolescents.

Calcaterra V, Nappi R, Regalbuto C, De Silvestri A, Incardona A, Amariti R Front Endocrinol (Lausanne). 2020; 11:229.

PMID: 32362875 PMC: 7181383. DOI: 10.3389/fendo.2020.00229.


CTLA-4 Expression Inversely Correlates with Kidney Function and Serum Immunoglobulin Concentration in Patients with Primary Glomerulonephritides.

Grywalska E, Smarz-Widelska I, Mertowski S, Gosik K, Mielnik M, Podgajna M Arch Immunol Ther Exp (Warsz). 2019; 67(5):335-349.

PMID: 31177287 PMC: 6732130. DOI: 10.1007/s00005-019-00548-3.


Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.

Chen X, Hu Z, Liu M, Li H, Liang C, Li W BMC Med Genet. 2018; 19(1):171.

PMID: 30223781 PMC: 6142355. DOI: 10.1186/s12881-018-0665-y.


CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function.

Chen Y, Chen S, Gu Y, Feng Y, Shi Y, Fu Q Sci Rep. 2018; 8(1):10074.

PMID: 29973665 PMC: 6031668. DOI: 10.1038/s41598-018-28423-9.


References
1.
Jacobson E, Tomer Y . The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun. 2007; 28(2-3):85-98. PMC: 2043086. DOI: 10.1016/j.jaut.2007.02.006. View

2.
Wang P, Chen I, Liu R, Hsieh C, Hsi E, Juo S . Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study. J Clin Endocrinol Metab. 2007; 92(7):2513-8. DOI: 10.1210/jc.2006-2761. View

3.
Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M . CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med Genet. 2007; 8:3. PMC: 1802068. DOI: 10.1186/1471-2350-8-3. View

4.
Chu X, Dong C, Lei R, Sun L, Wang Z, Dong Y . Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. Genes Immun. 2009; 10(3):260-6. DOI: 10.1038/gene.2009.3. View

5.
Dechairo B, Zabaneh D, Collins J, Brand O, Dawson G, Green A . Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet. 2005; 13(11):1223-30. DOI: 10.1038/sj.ejhg.5201485. View